NCT07613086

Brief Summary

The goal of this clinical trial is to learn if a self-efficacy program can improve diabetes self-management behaviors in adults with Type 2 Diabetes Mellitus attending primary health centers (Puskesmas) in Yogyakarta, Indonesia. The main questions it aims to answer are:

  • Does a self-efficacy program improve diabetes self-management behaviors (measured by the Summary of Diabetes Self-Care Activities/SDSCA)?
  • Does a self-efficacy program enhance diabetes self-efficacy (measured by the Diabetes Self-Efficacy Scale)? Researchers will compare participants receiving the self-efficacy program (intervention group) to a waiting-list control group to see if the program leads to greater improvements in self-management and self-efficacy. Participants will:
  • Attend four weekly group sessions (60-90 minutes each) covering diabetes knowledge, goal setting, self-monitoring, and peer support
  • Complete questionnaires on diabetes self-management and self-efficacy at baseline and after the intervention period
  • Selected participants in the intervention group will take part in semi-structured interviews about their experience with the program

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 14, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 22, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2019

Completed
6.4 years until next milestone

First Submitted

Initial submission to the registry

May 18, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 29, 2026

Completed
Last Updated

May 29, 2026

Status Verified

May 1, 2026

Enrollment Period

1 month

First QC Date

May 18, 2026

Last Update Submit

May 23, 2026

Conditions

Keywords

self-efficacy programmixed methodself-managementtype 2 diabetes mellitus

Outcome Measures

Primary Outcomes (3)

  • Diabetes Self-Management

    Measured using the Summary of Diabetes Self-Care Activities (SDSCA) questionnaire, which assesses self-care behaviors across five domains: general diet, specific diet, exercise, blood glucose testing, and foot care. Scores represent the number of days per week (0-7) participants performed each self-care activity.

    Baseline (pre-intervention) and immediately post-intervention (after 4 weeks)

  • Diabetes Self-Efficacy

    Measured using the Diabetes Self-Efficacy Scale (DSES), which assesses participants' confidence in performing diabetes self-management tasks. The scale uses a Likert-type response format with higher scores indicating greater self-efficacy.

    Baseline (pre-intervention) and immediately post-intervention (after 4 weeks)

  • Participants' Experiences with the Self-Efficacy Program

    Qualitative data collected through semi-structured interviews with a purposive subsample of intervention group participants. Interviews explored participants' perceptions, experiences, and perceived impact of the self-efficacy program on their diabetes self-management. Data were analyzed using thematic analysis.

    Post-intervention (after completion of the 4-week program)

Study Arms (2)

Self-Efficacy Program Group

EXPERIMENTAL

Participants at the intervention Puskesmas received a structured self-efficacy program consisting of four weekly group sessions (60-90 minutes each) delivered by a trained nurse researcher. Sessions covered diabetes knowledge enhancement, personal goal setting, self-monitoring techniques, peer experience sharing, problem-solving strategies, progress review, and relapse prevention planning. The program was grounded in Bandura's Self-Efficacy Theory, targeting mastery experience, vicarious experience, verbal persuasion, and physiological/emotional states.

Behavioral: Self-Efficacy Program for Diabetes Self-Management

Waiting-List Control Group

NO INTERVENTION

Participants at the control Puskesmas received usual care as routinely provided by the primary health center (Puskesmas). No additional intervention was given during the study period. Participants in this group were offered the self-efficacy program after data collection was completed.

Interventions

A structured group-based behavioral intervention grounded in Bandura's Self-Efficacy Theory. The program consisted of four weekly sessions (60-90 minutes each) facilitated by a trained nurse researcher. Session 1 focused on diabetes knowledge enhancement and personal goal setting. Session 2 covered self-monitoring techniques and identifying barriers to self-care. Session 3 involved peer experience sharing and problem-solving strategies. Session 4 included review of progress, reinforcement of skills, and relapse prevention planning. The intervention targeted four sources of self-efficacy: mastery experience, vicarious experience, verbal persuasion, and physiological/emotional states.

Self-Efficacy Program Group

Eligibility Criteria

Age40 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • individuals diagnosed with Type 2 Diabetes Mellitus for a minimum of one year;
  • exhibiting low or moderate scores on the Diabetes Self-management Scale;
  • no prior experience with similar programs or concurrent participation in other related activities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Puskesmas (Primary Health Care) Gedongtengen

Yogyakarta, DI Yogyakarta, 55272, Indonesia

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 18, 2026

First Posted

May 29, 2026

Study Start

September 14, 2019

Primary Completion

October 22, 2019

Study Completion

December 15, 2019

Last Updated

May 29, 2026

Record last verified: 2026-05

Locations